PUBLISHER: Global Market Insights Inc. | PRODUCT CODE: 1618139
PUBLISHER: Global Market Insights Inc. | PRODUCT CODE: 1618139
Femtech Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2024 - 2032
The Global Femtech Market was valued at USD 55.1 billion in 2023 and is projected to expand at a compound annual growth rate (CAGR) of 12.8% from 2024 to 2032. This growth is primarily fueled by the increasing prevalence of chronic and infectious diseases affecting women. A notable rise in chronic health conditions such as cancer, diabetes, hypertension, and mental health disorders, along with infectious diseases like HIV and tuberculosis, has had a significant impact on the female population. This growing burden highlights the urgent need for effective healthcare solutions tailored to address these pressing health issues. The femtech market is categorized into products, software, and services.
In 2023, the software segment emerged as the leader, generating USD 28.5 million in revenue. The growing recognition of women's health, particularly in previously overlooked areas such as menstrual and reproductive health, is a major driver of growth in this segment. The substantial number of women of reproductive age experiencing menstrual cycles each month further emphasizes the potential for innovation and development within this market. In terms of application, the femtech market encompasses reproductive health, pregnancy care, maternal/postpartum and nursing care, integrative physical and mental health, and overall well-being.
The reproductive health segment dominated in 2023, capturing 43.8% of the market share. Increased awareness surrounding women's unique health challenges-including fertility, menstruation, pregnancy, and menopause-has surged, largely driven by educational initiatives and social movements. This heightened awareness has cultivated a more informed consumer base eager to access specialized reproductive health solutions. North America accounted for USD 17.8 billion in femtech market revenue in 2023, with a projected growth rate of 13% CAGR from 2024 to 2032. This growth is driven by rising awareness of women's health issues and the benefits of femtech innovations.Women are continuously seeking individualized, available, and effective healthcare alternatives. Many women have reported delaying or forgoing healthcare due to cost concerns, indicating a significant demand for more accessible solutions in the market.
| Market Scope | |
|---|---|
| Start Year | 2023 |
| Forecast Year | 2024-2032 |
| Start Value | $55.1 Billion |
| Forecast Value | $135.9 Billion |
| CAGR | 12.8% |
Table of Contents
Chapter 1 Methodology & Scope
- 1.1 Market scope & definition
- 1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
- 1.3 Base estimates & calculations
- 1.3.1 Base year calculation
- 1.3.2 Key trends for market estimation
- 1.4 Forecast model
- 1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.5.2 Data mining sources
Chapter 2 Executive Summary
- 2.1 Industry 360° synopsis
Chapter 3 Industry Insights
- 3.1 Industry ecosystem analysis
- 3.2 Industry impact forces
- 3.2.1 Growth drivers
- 3.2.1.1 Usage of digital technology to manage women health in developed countries
- 3.2.1.2 Improving access to women care in remote areas
- 3.2.1.3 Growing awareness regarding women health and wellness in developing countries
- 3.2.1.4 Increasing burden of chronic and infectious diseases among the female population
- 3.2.1.5 Growing investments in femtech industry
- 3.2.2 Industry pitfalls & challenges
- 3.2.2.1 Lack of awareness about femtech products and applications
- 3.2.1 Growth drivers
- 3.3 Growth potential analysis
- 3.4 Regulatory landscape
- 3.4.1 U.S.
- 3.4.2 Europe
- 3.4.3 Asia Pacific
- 3.5 Technological landscape
- 3.6 Future market trends
- 3.7 Porter's analysis
- 3.8 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
- 4.1 Introduction
- 4.2 Company matrix analysis
- 4.3 Competitive analysis of major market players
- 4.4 Competitive positioning matrix
- 4.5 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Type, 2021 - 2032 ($ Mn)
- 5.1 Key trends
- 5.2 Product
- 5.3 Software
- 5.4 Services
Chapter 6 Market Estimates and Forecast, By Application, 2021 - 2032 ($ Mn)
- 6.1 Key trends
- 6.2 Reproductive health
- 6.2.1 Menstrual cycle & fertility
- 6.2.1.1 Contraception
- 6.2.1.2 Pregnancy testing
- 6.2.1.3 Fertility testing & conception support
- 6.2.1.4 Cycle monitoring
- 6.2.1.5 Reproductive health guidance
- 6.2.2 Menopause
- 6.2.1 Menstrual cycle & fertility
- 6.3 Pregnancy care
- 6.3.1 Pregnancy progress insights apps
- 6.3.2 Pregnancy exchange network & parental education
- 6.3.3 Pregnancy health guidance
- 6.3.4 Abortion & miscarriage support
- 6.4 Maternal/postpartum and nursing care
- 6.4.1 Postpartum support
- 6.4.2 Breastfeeding & lactation support
- 6.4.3 Personal development
- 6.5 Integrative physical and mental health & overall well-being
- 6.5.1 Pain relief and management
- 6.5.2 Pregnancy health monitoring
- 6.5.3 Parental health
- 6.5.4 Disease prevention and detection
- 6.6 Other applications
Chapter 7 Market Estimates and Forecast, By End Use, 2021 - 2032 ($ Mn)
- 7.1 Key trends
- 7.2 Direct-to-consumer
- 7.3 Hospitals
- 7.4 Fertility clinics
- 7.5 Surgical centers
- 7.6 Diagnostic centers
- 7.7 Other end users
Chapter 8 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)
- 8.1 Key trends
- 8.2 North America
- 8.2.1 U.S.
- 8.2.2 Canada
- 8.3 Europe
- 8.3.1 Germany
- 8.3.2 UK
- 8.3.3 France
- 8.3.4 Spain
- 8.3.5 Italy
- 8.3.6 Russia
- 8.3.7 Rest of Europe
- 8.4 Asia Pacific
- 8.4.1 China
- 8.4.2 Japan
- 8.4.3 India
- 8.4.4 Australia
- 8.4.5 Rest of Asia Pacific
- 8.5 Latin America
- 8.5.1 Brazil
- 8.5.2 Mexico
- 8.5.3 Rest of Latin America
- 8.6 Middle East and Africa
- 8.6.1 South Africa
- 8.6.2 Saudi Arabia
- 8.6.3 Rest of Middle East and Africa
Chapter 9 Company Profiles
- 9.1 Amazon.com, Inc.
- 9.2 AVA Women
- 9.3 Clue (BioWink GmbH)
- 9.4 Conceivable
- 9.5 Daysy (Valley Electronics AG)
- 9.6 Elvie (Chiaro Technology Ltd.)
- 9.7 Flo Health Inc.
- 9.8 Google Nest (Alphabet Inc.)
- 9.9 HeraMED Limited
- 9.10 LactApp Women's Health S.L.
- 9.11 LunaJoy
- 9.12 MASIMO CORPORATION
- 9.13 Maven Clinic
- 9.14 Nanit
- 9.15 Natural Cycles
- 9.16 Peppy Health Limited
- 9.17 Preglife
- 9.18 Pregnancy+ (Koninklijke Philips N.V.)
- 9.19 Soula - AI (Mamatech Ltd.)
- 9.20 Univfy Inc.
